Malaria epidemic and drug resistance, Djibouti

Emerging Infectious Diseases

Volumn 11, Issue 2, 2005, Pages 317-321

  Rogier, Christophe ^a   Pradines, Bruno ^a   Bogreau, H ^a   Koeck, Jean Louis ^b,c   Kamil, Mohamed Ali ^d   Mercereau Puijalon, Odile ^e  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

^b Centre Hospitalier des Armees Bouffard   (Djibouti)

^c HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

^d Ministry of Health   (Djibouti)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; CYCLOGUANIL; PROGUANIL; PYRIMETHAMINE; SULFADOXINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; EPIDEMIC; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VITRO STUDY; INCIDENCE; INFECTION SENSITIVITY; LABORATORY DIAGNOSIS; MALARIA; MALARIA CONTROL; MUTATIONAL ANALYSIS; PARASITE INCIDENCE; PARASITE ISOLATION; PARASITE PREVALENCE; PARASITEMIA; PLASMODIUM FALCIPARUM; PUBLIC HOSPITAL; REVIEW;

EID: 13744252160     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1102.040108     Document Type: Review

References (14)

1. Carteron B, Morvan D, Rhodain F. Le problème de l'endémie palustre dans la République de Djibouti. Med Trop (Mars). 1978;38:837-46.
2. Shidrawi GR. Rapport sur une visite en République de Djibouti du 14 janvier au 11 février 1982. OMS/EM/MAL/190. Geneva: World Health Organization; 1982.
3. Louis JP, Albert JP. Le paludisme en République de Djibouti. Stratégie de contrôle par la lutte antilarvaire biologique: Poissons larvivores autochtones (Aphanius dispar) et toxines batériennes. Med Trop (Mars). 1988;48:127-31.
4. Courtois D, Mouchet J. Etude des populations de culicides en TFAI. Med Trop (Mars). 1970;30:837-46.
5. Fox E, Bouloumie J, Olson JG, Tible D, Lluberas M, Shakib SO, et al. Plasmodium falciparum voyage en train d'Ethiopie à Djibouti. Med Trop (Mars). 1991;51:185-9.
6. Rodier GR, Parra JP, Kamil M, Chakib SO, Cope SE. Recurrence and emergence of infectious diseases in Djibouti city. Bull World Health Organ. 1995;73:755-9.
7. Zwetyenga J, Rogier C, Tall A, Fontenille D, Snounou G, Trape Jf, et al. No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Am J Trop Med Hyg. 1998;59:726-35.
8. Nei M. Estimation of average heterozygosity and genetic distance from small number of individuals. Genetics. 1978;89:583-90.
9. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185:380-8.
10. Reeder JC, Rieckmann KH, Genton B, Lorry K, Wines B, Cowman AF. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am J Trop Med Hyg. 1996;55:209-13.
11. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257-63.
12. Pradines B, Rogier C, Fusai T, Tall A, Trape JF, Doury JC. In vitro activity of artemether and its relationship to other standard antimalarial drugs against West African isolates. Am J Trop Med Hyg. 1998;58:354-7.
13. Anderson TJ, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, Mollinedo R, et al. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol. 2000;17:1467-82.
14. Plowe CV, Kublin JG, Dzinjalamala FK, Kamwendo DS, Mukadam RA, Chimpeni P, et al. Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study. BMJ. 2004;328:545-8.